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Abstract
Long non-coding RNAs (lncRNAs) are an emerging class of regulatory RNA that may be implicated in psychiatric
disorders. Here we performed RNA-sequencing in the rostral anterior cingulate cortex of 26 depressed suicides and 24
matched controls. We first performed differential lncRNA expression analysis, and then conducted Weighted Gene Co-
expression Network Analysis (WGCNA) to identify co-expression modules associating with depression and suicide. We
identified 23 differentially expressed lncRNAs (FDR < 0.1) as well as their differentially expressed overlapping and
antisense protein-coding genes. Several of these overlapping or antisense genes were associated with interferon
signaling, which is a component of the innate immune response. Using WGCNA, we identified modules of highly co-
expressed genes associated with depression and suicide and found protein-coding genes highly connected to
differentially expressed lncRNAs within these modules. These protein-coding genes were located distal to their
associated lncRNAs and were found to be part of several GO terms enriched in the significant modules, which include:
cytoskeleton organization, plasma membrane, cell adhesion, nucleus, DNA-binding, and regulation of dendrite
development and morphology. Altogether, we report that lncRNAs are differentially expressed in the brains of
depressed individuals who died by suicide and may represent regulators of important molecular functions and
biological processes.
Introduction
Depression is a leading cause of disability affecting 300
million people worldwide, according to estimates by
World Health Organization1, and the single most
important risk factor for suicide2. Various biological sys-
tems are believed to underlie depression3 and in order to
gain insight into its possible underlying pathways, studies
have investigated gene expression patterns that are altered
in the depressed brain. More recently, there has been
growing interest in the investigation of the epigenetic
factors explaining gene dysregulation in this disorder4.
Among these, non-coding RNAs have been identified as
important regulators of gene expression. Importantly, an
emerging class of non-coding RNAs, called long non-
coding RNAs (lncRNAs), have recently become identified
as important players involved in the mechanisms under-
lying disease, including mental health disorders5.
LncRNAs are defined as RNA molecules greater than
200 bp in length with low protein-coding potential. They
are found throughout the genome and are generally
categorized based on their relation to other known genes.
For example, lncRNAs can be antisense, sense over-
lapping, intronic, and intergenic6. Early in their investi-
gation, it was unclear whether lncRNAs were functional
or products of transcriptional noise. Recent investigations
revealed that lncRNAs exhibit sequence conservation near
their promoters, and high secondary structural con-
servation7. In addition, they show high tissue-specific8 and
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activity-dependent9,10 expression, therefore supporting
the hypothesis that they fulfill biological functions.
LncRNAs are enriched in nuclear fractions11, suggesting
that they interact with chromatin and DNA. Indeed, the
expression of protein-coding genes has been shown to be
regulated by overlapping or antisense lncRNAs12. For
example, the antisense lncRNA KCNQ1OT1 interacts
with histone methyl-transferases to form a repressive
domain around the KCNQ1 gene, thereby regulating its
expression13. While such local cis regulatory mechanisms
represent an important mode of lncRNA function, their
interaction with protein complexes regulating the
expression of more distal genes in trans, has also been
described. For example, the lncRNA HOTAIR found in
the HOXC locus on chromosome 12, interacts with PRC2
to regulate the expression of HOXD locus genes on
chromosome 214,15. As well, the process of lncRNA
transcription per se may serve to mediate certain reg-
ulatory processes, such as the recruitment of transcription
factors and other regulatory proteins, affecting the
expression of target genes16. Finally, owing to their ability
to fold into modular secondary structures, lncRNAs have
also been reported to act as molecular sinks for particular
proteins and to act as scaffolds upon which various pro-
tein complexes can be assembled17.
While there have already been some reports of asso-
ciations between lncRNAs and psychiatric pheno-
types18,19, little is known about their role in depression
and suicide. The neuropathology of suicide broadly
implicates a dysregulated stress response, immune, and
neurotransmitter/neuromodulator systems that exhibit
altered gene expression in the brains of depressed indi-
viduals who died by suicide20. Our group and others have
previously reported changes in the expression of
polyamine-related genes in suicide brains21, some of
which are regulated by miRNAs, another class of non-
coding RNAs22,23. Given that lncRNAs have also been
shown to fulfill important regulatory functions, we aim to
explore whether they may also be important in con-
tributing to gene dysregulation in the brains of depres-
sed suicides. While a handful of studies have reported
changes in lncRNA expression in the peripheral blood of
depressed patients24, none have broadly characterized
lncRNAs in the brains of depressed individuals who died
by suicide, to our knowledge. Thus, there is a great need
for the characterization of lncRNA expression and for
the identification of dysregulated genes targeted by
lncRNAs in the brain and in the context of depression
and suicide.
Here we report a transcriptome-wide lncRNA expres-
sion profiling in the rostral anterior cingulate cortex
(rACC) of depressed suicides and controls, using RNA-
sequencing (RNA-seq). We focused on the ACC as it is a
critical structure for the assessment of emotional salience
and the processing of motivational information25. ACC
dysfunction is implicated in depression as altered gray
matter volume as well as increased metabolic activity have
been found in depressed subjects which are ameliorated
with antidepressant treatment26. Furthermore, several
studies have previously identified differentially expressed
genes in the ACC of suicides, including stress27 and
myelin28 related genes. In the present study, we identified
and validated several differentially expressed lncRNAs, as
well as their potential proximally regulated cis target
genes by identifying antisense or overlapping dysregulated
protein-coding genes. Furthermore, we combined
Weighted Gene Co-expression Network Analysis
(WGCNA)29 with Gene Ontology (GO) in order to
identify potential lncRNA targets located distal to the
lncRNA gene and to determine their biological and
molecular significance in the brains of depressed indivi-
duals who died by suicide.
Materials and methods
Cohort and overlap with previous studies
Ethical approval was obtained from The Institutional
Review Board of the Douglas Mental Health Institute, and
written informed consent was obtained from the family.
Individuals who died by suicide during a major depressive
episode (N= 26), as well as control subjects who died
naturally or by accident, with no history of psycho-
pathology (N= 24), were included in this study. The
sample size was chosen based on previous studies con-
ducted by our group to investigate molecular changes in
the brain of depressed individuals30,31. Psychological
autopsies were performed by trained clinicians on both
controls and cases, as described previously and validated
by our group and others32,33. Diagnoses were assigned
based on DSM-IV criteria by panels blind to group status.
There were no significant differences in age, post mortem
interval (PMI), brain pH, and RNA-integrity number
(RIN) values between the two groups (Supplementary
Table 1). Both male and female subjects were used in this
study and there were no significant differences in the
proportion of males and females in each group (Supple-
mentary Table 1). A few depressed subjects had substance
use disorders, a factor that was explored and controlled
for in downstream analyses. Of note, the RNA-sequencing
data that was generated using this cohort was part of a
previous study (see28) that focused on coding RNA tran-
scripts. We have included the details of this analysis in the
supplementary materials and methods. However, here we
have conducted and report separate studies specifically
devoted to the investigation of lncRNAs.
Tissue dissection
Brain tissue was obtained from the Douglas-Bell Canada
Brain Bank (douglasbrainbank.ca/). 200mg of tissue was
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dissected from the rACC on 0.5 cm-thick coronal sec-
tions, as described in supplementary material (Supple-
mentary Figure 1).
RNA-sequencing
RNA was extracted from rACC tissue using the
RNeasy Lipid Tissue Mini Kit (Qiagen, Valencia, CA,
USA). RNA quality (RIN values) was measured using an
Agilent 2100 Bioanalyzer (Agilent Technologies, Ger-
many), and only samples with RIN values greater than 5
were used. RNA-seq libraries were prepared by McGill
University’s Innovation Centre, as described pre-
viously34, using the Ribo-Zero Gold rRNA Removal Kit
(Illumina, MRZG12324, USA) and the TruSeq Stranded
Total RNA Library Prep Kit (Illumina, RS-122-2201,
USA). DNA libraries were pooled into groups of 3–4 per
lane of an Illumina’s HiSeq 2000 (Illumina, USA), and
loaded across 2 flow cells to generate 100 base pair (bp)
paired-end reads.
Data processing and RNA-seq differential gene expression
analysis
As described previously35, quality control was first
performed. Trimmed reads were aligned to the human
hg19 reference genome, using TopHat236. We used a
lncRNA-specific gene annotation from GENCODE
(Release 19 (GRCh37.p13) Long non-coding RNA gene
annotation), which contains 13,000 annotated lncRNA
genes, to count reads aligning with lncRNA genes using
HTSeq-Count37. We first focused only on lncRNA gene
expression to increase our ability and power to detect
significantly differentially expressed lncRNAs using
DESeq2 and to overcome normalization bias38. While this
approach can lead to increased assignment of sequenced
reads to lncRNA gene features, we followed up these
results with qPCR experiments using primers carefully
designed to target RNA sequences specific for regions
unique to these lncRNAs. LncRNAs with an average of
<20 reads per library were discarded from further analysis
as they are more likely to be transcriptional noise. Fifteen
genes were removed due to having sequenced reads
accounting for >0.4% of the total number of reads, which
could skew the data normalization. These were as follows:
BCYRN1, KCNQ1OT1, LINC00657, MALAT1, MEG3,
MIAT, NEAT1, NEFL, OIP5-AS1, RMRP, RN7SL1,
RPPH1, SNHG14, SNORD3A, SYN2. A principal compo-
nent analysis (PCA) was performed to identify and eval-
uate effects of covariates. Age, brain pH, PMI, RIN, sex,
and substance use disorder (SUD) status were controlled
for in the differential lncRNA expression analysis. The top
lncRNAs passing an adjusted p-value (FDR < 0.1) were
selected for further investigation. The expression of
protein-coding genes was similarly characterized from our
RNA-seq dataset using the Comprehensive gene annota-
tion from GENCODE (Release 19, GRCh37.p13).
cDNA synthesis
Invitrogen’s M-MLV reverse transcriptase (Thermo-
Fischer, 28025013, USA) and random hexamer primers
were used for cDNA synthesis. For the Biomark HD
(Fluidigm, USA) high throughput qPCR validation, spike
in RNAs (C1™ RNA Standard Assays, RNA spikes 1, 4, and
7, Fluidigm, USA) were incorporated into the sample
RNAs to serve as controls during cDNA synthesis.
Primer design
We designed and tested qPCR primers (Integrated DNA
Technologies, USA) for differentially expressed lncRNA,
potential lncRNA target genes, and housekeeping genes
(HKG) (Supplementary Table 2). PCR products amplified
from pooled sample cDNA were run on a PerkinElmer’s
microfluidic LabChip to check the accuracy and specifi-
city of each primer pair.
BioMark HD high throughput RT-qPCR validation
Pre-amplification
LncRNA and HKG primers were pooled and 15 cycles
of PCR pre-amplification, using SsoAdvanced PreAmp
Supermix (Bio-Rad, 1725160, USA), were done for each
sample. Samples were then diluted 5×.
High throughput qPCR
We used Fluidigm’s Biomark HD to validate lncRNA
expression. Pre-amplified samples and primers were loa-
ded onto a 96 by 96 integrated fluidic circuit (IFC) chip
(Fluidigm, USA). Gene expression was quantified by the
relative standard curve method31, and using the SsoFast
EvaGreen Supermix (Bio-Rad, 1725210, USA). LncRNA
expression was normalized against the geometric mean of
3 HKG’s: ARHGEF12, B-ACTIN, and TUBA1A. Each of
these 3 housekeeping genes was stable across conditions
in both the RNA-seq and qPCR data (Supplementary
Table 3). To assess their stability in qPCR data, each
housekeeping gene was normalized to the geometric
mean of the other 2 housekeeping genes.
qPCR
RT-qPCR was done to validate the differential expres-
sion of potential lncRNA cis-targets as described
previously31.
Weighted gene co-expression network analysis and
identification of depression modules
We used WGCNA29 to identify co-expression modules
using RNA-seq expression data from controls and
depressed suicides combined. A 1-step network con-
struction and module detection method was used along
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with the Dynamic Tree Cut method. A soft thresholding
power of 5 was selected according to an analysis of net-
work topology, the TOMType was set to the default
parameter “unsigned”, and the branch mergeCutHeight
was set at 0.4. Module detection was done in a single
block with a maximum block size of 25,000 genes. We
then searched for associations between modules and
various sample traits. By default, the WGCNA package
correlates a module eigengene with each external sample
trait to identify significant associations. Such associations,
however, do not take into account potential confounding
contributions of other sample traits. To overcome this, we
investigated associations between depression and module
eigengenes while controlling for co-variates, as described
previously:39 eigengenes were used in a general linear
model (GLM) using depression as a fixed factor while
controlling for sample traits (Sex, SUD, age, brain pH,
PMI, and RIN) as covariates. The significance of module
eigengene associations with depression were corrected by
the Benjamini-Hochberg procedure (FDR < 0.1).
TopGO gene ontology analysis
To determine the functional significance of modules
associated with depression and suicide, we performed
gene ontology enrichment analysis on genes within each
depression and suicide associated module using the
topGO package40. We chose to use the elim algorithm
and Fisher test statistic to identify significantly enriched
gene ontologies. The org.Hs.eg.db annotation package
was used for gene mapping to GO terms and we specified
a gene universe consisting of all the genes identified by
our RNA-seq analysis.
qPCR statistical analysis
Statistical analysis for qPCR data was done using the
SPSS software. A general linear model was used to
determine the significance of the Group factor (depressed
suicides vs control) on gene expression while taking into
account Sex, SUD, brain pH, PMI, age, and RIN as co-
variates. Some qPCR lncRNA expression data sets were
log transformed, to ensure the normality of the data and
equal variances, in order to carry out parametric statistical
testing. Grubb’s outlier test was used to identify sample
outliers.
Results
Exploratory analysis
RNA-sequencing produced an average of 56 million
reads per subject with 43 million reads aligning to the
human genome. The expression data for 2670 lncRNAs
were included in downstream analysis, after filtering, with
an average of 432 000 reads aligning to lncRNA genes per
library. Sex was a significant covariate that clearly
differentiated samples in the PCA (Supplementary Figure
2A). This was due, as expected, to the 1000-fold higher
expression of lncRNA XIST in females compared to
males, which contributed significantly to sample varia-
tions in lncRNA expression. After removing reads align-
ing to the XIST gene, much of the variation due to sex was
eliminated (Supplementary Figure 2B). However, sex was
still a significant factor that could account for variations in
gene expression and was included as a co-variate in
subsequent analyses.
At the moment of death, 22% of the subjects had tox-
icological evidence of benzodiazepines and 14% had evi-
dence of acetaminophen. Other medications were present
in less than 10% of the total sample and were not eval-
uated (Supplementary Table 4A). Presence of neither
medication was associated with the top 4 principal com-
ponents (each accounting for greater than 5% of the total
expression variation) indicating they were not likely to be
significant factors affecting lncRNA expression (Supple-
mentary Table 4B). Furthermore, including either medi-
cation as a covariate in our downstream qPCR analyses
did not have a significant effect on lncRNA differential
expression (Supplementary Table 5A and 5B), confirming
these medications were not significant factors contribut-
ing to lncRNA expression. As there was significant over-
lap between samples exhibiting presence of both
medications (4 out of 7 subjects with acetaminophen also
had benzodiazepines), we evaluated the effects of each
medication individually.
Hierarchical clustering was done to visualize between-
sample variability, and their relation to sample traits
(Supplementary Figure 2C). No significant outliers were
identified in these analyses, and all libraries were included
in differential expression analysis.
Differential lncRNA expression analysis
Differential expression analysis was performed for the
aforementioned 2670 lncRNAs. When considering nom-
inal p values (p < 0.05), approximately 13% of lncRNAs
(364/2670) were differentially expressed, with 60% of
these being downregulated in depressed suicides (217/
364) (Fig. 1a, and Supplementary Table 10).
23 differentially expressed lncRNAs passed genome-
wide multiple testing corrections (Fig. 1b). Interestingly,
of these, more were upregulated (15/23) than down-
regulated (Table 1). Of note, 2 of these 23 lncRNAs were
identified as processed transcripts (AC004019.18 and
DYX1C1-CCPG1) that almost perfectly overlapped with
protein-coding genes located on the same strand. As it
would be extremely challenging to discriminate expres-
sion of these two lncRNAs from the expression of their
corresponding protein-coding genes, they were excluded
from further analyses.
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Validating differentially expressed lncRNA with RT-qPCR
We then conducted qPCR experiments to validate the
most significant findings, and designed primer pairs for 21
lncRNAs. Only 13 primer pairs, however, allowed for
accurate and efficient quantification of the corresponding
lncRNAs (Table 1). This was expected, as several factors
contribute to the technical difficulty in designing primers
to quantify lncRNA expression, such as low expression
levels when compared to mRNA, overlapping organiza-
tion with protein-coding genes, or poorly characterized
splicing patterns41.
We found highly significant correlations between RNA-
seq and RT-qPCR expression values for each lncRNA
across the 50 samples (Supplementary Table 6), indicating
high reliability across these experimental approaches.
Furthermore, we validated significant differential
expression for 9 out of the 13 lncRNAs that we could
reliably quantify by qPCR (Supplementary Figure 3). Of
these, 4 were antisense (CTC-487M23.5, RP11-273G15.2,
RP11-326I11.3, and RP1-269M15.3), 1 was sense-
overlapping (RP11-96D1.10), 1 was sense-intronic (CTD-
2647L4.4), and 3 were intergenic (RP11-453F18_B.1,
RP11-434C1.1, and ZNF833P).
Identifying potential antisense or overlapping lncRNA cis-
targets
Protein-coding genes antisense to or overlapping with
differentially expressed lncRNAs were identified as
potential lncRNA cis targets. Using full transcriptomic
RNA-seq data available from the same samples included
in this study, we found the expression of 6 lncRNAs were
significantly correlated with one antisense or overlapping
protein-coding gene each (Fig. 2a–g). The protein-coding
genes were IRF2, LY6E, HMBOX1, PTPRT, NFATC3, and
REEP5. All of these genes were nominally differentially
expressed (p < 0.05) except REEP5 (Supplementary Table
7). Differential expression of 3 out of 5 of these protein-
coding genes (IRF2, LY6E, and HMBOX1) was further
validated by qPCR (Fig. 3a–e). IRF2 is antisense to
lncRNA RP11-326I11.3, and encodes a transcription fac-
tor (TF) involved in interferon signaling42. LY6E is anti-
sense to lncRNA RP11-273G15.2 and is an interferon
stimulated gene with immuno-modulatory functions43.
Finally, lncRNA CTD-2647L4.4 is sense intronic to
HMBOX1, which encodes a TF involved in transcriptional
repression, including of interferon genes44.
Identifying other potential lncRNA cis and trans targets
LncRNAs have also been shown to regulate more distal
gene targets through both cis and trans regulatory
mechanisms45. To identify such potential regulatory tar-
gets, we took a 2-step approach: first, we performed a
WGCNA analysis to identify modules of co-expressed
genes; then, we searched within each module for sig-
nificant correlations between expression of lncRNAs and
distal protein-coding genes. The WGCNA network was
constructed using both protein-coding and lncRNAs
genes (Supplementary Figure 4) and 10 distinct modules
of co-expressed genes were detected (Supplementary
Table 8). Among these, the Brown and Blue modules
showed significant associations with depression and sui-
cide (Supplementary Table 8). Interestingly, 6 of the
previously validated differentially expressed lncRNAs
were members of the Blue module and 1 was a member of
the Brown module (Supplementary Table 9). To deter-
mine the functional significance of these 2 modules, we
performed Gene Ontology (GO) analysis and report in
Supplementary Figures 5 and 6 the top 10 GO terms in
each GO class for both the Brown and Blue modules,
respectively.
Fig. 1 Transcriptome wide lncRNA differential expression
analysis. a A volcano plot summarizing the differential expression of
2670 long non-coding RNAs (lncRNAs) with p values plotted against
their fold changes. b An MA plot with LncRNA fold changes plotted
against their mean expression levels (normalized read counts). The red
points indicate lncRNAs with p-adj (FDR) < 0.1
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Table 1 Top 23 differentially expressed long non-coding RNAs (p-adj < 0.1)
Name Strand Biotype baseMean log2FoldChange (padj)
SNORD3C - lincRNA 130.39 0.66 0.000
RP11-453F18_B.1 - lincRNA 37.09 -0.55 0.006
LLNLF-65H9.1 + lincRNA 56.52 0.43 0.015
RP11-96D1.10 + sense overlap 104.83 -0.32 0.048
RP1-269M15.3 + antisense 77.13 0.36 0.070
AC004019.18 + lincRNA 49.63 -0.41 0.098
AC006003.3 - sense intronic 30.13 0.37 0.098
AC012507.3 + antisense 27.50 0.34 0.098
AC013460.1 + lincRNA 38.63 0.37 0.098
C9orf106 + lincRNA 34.47 0.34 0.098
CTC-487M23.5 + antisense 23.55 -0.38 0.098
DYX1C1-CCPG1 - Process.
Trscrpt. 
2725.48 0.16 0.098
CTD-2647L4.4 + sense intronic 115.34 -0.26 0.098
RP1-63G5.5 - sense overlap 90.89 0.25 0.098
RP11-1186N24.5 - lincRNA 676.12 0.23 0.098
RP11-1391J7.1 - antisense 46.84 0.32 0.098
RP11-143K11.5 + sense overlap 146.45 0.34 0.098
RP11-273G15.2 - antisense 124.28 0.28 0.098
RP11-326G21.1 + antisense 54.38 -0.45 0.098
RP11-326I11.3 + antisense 47.51 -0.36 0.098
RP11-326I11.5 - sense intronic 30.22 -0.33 0.098
RP11-434C1.1 + lincRNA 238.94 0.25 0.098
ZNF833P + lincRNA 48.44 0.26 0.098
qPCR primers were successfully designed for lncRNAs highlighted in blue. LncRNAs highlighted in red were processed transcripts, which contained exons on the same
strand and overlapping significantly with protein-coding genes and were omitted from further analyses
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Within the Brown and Blue modules, we then sought to
determine associations between protein-coding genes and
lncRNAs that were not antisense or overlapping with each
other. To this end, we first identified the top 10 genes with
the highest weighted correlation with each depression-
associated lncRNA within the Brown and Blue modules. Of
the top 10 most co-expressed genes with each lncRNA,
those which showed nominal differential expression (p <
0.05) and also associated with a GO term significantly
enriched within the corresponding co-expression module
may represent potential biologically relevant lncRNA targets
(Table 2). In this way, we identified 15 distinct protein-
coding genes in the Blue module and 5 protein-coding genes
in the Brown module that associated with differentially
expressed lncRNAs and depression and suicide. In the Blue
module, these protein-coding genes were predominantly
associated with the plasma membrane, regulation of actin
organization binding, and cell adhesion, while those in the
Brown module were notably associated with the nucleus,
DNA-binding and regulation of transcription, and regulation
of dendrite development and morphogenesis.
Discussion
Differential lncRNA expression in major depression and
suicide
We found a significant number of lncRNAs were dys-
regulated, with a higher proportion showing decreased
expression in the rACC of depressed suicides. Recent
reports similarly characterized lncRNAs in the blood and
peripheral blood mononuclear cells (PBMCs) of depres-
sed patients. While one group reported a significantly
higher proportion of downregulated lncRNAs in
PBMCs46, another group reported a larger proportion of
upregulated lncRNAs in whole blood from depressed
subjects24. As lncRNAs are expressed in a highly tissue-
specific manner, it was not surprising to see no overlap
between the differentially expressed lncRNAs we identi-
fied in the brain and the top differentially expressed
lncRNAs identified in peripheral samples reported by
these previous studies. Whether lncRNA expression in the
CNS relates to their expression in the periphery in the
context of depression and suicide remains to be
investigated.
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Fig. 2 LncRNAassociationswithpotentialcisgenetargets. a–g Correlations (in terms of RNA-seq normalized read counts) between 6 differentially
expressed long non-coding RNAs (lncRNAs) and antisense or overlapping protein-coding genes identified as potential cis-targets are shown
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Of note, we identified RP1-269M15.3 as one of the top
differentially expressed lncRNAs whose expression was
previously reported to be stratified by 30 MDD related
SNPs in the nucleus accumbens47. Therefore, RP1-
268M15.3 expression and associated genetic variation
could contribute to depressive phenotypes, and should be
investigated further.
LncRNA associations with antisense and overlapping
genes
We found that the expression of 3 differentially
expressed lncRNAs were positively correlated with their
corresponding antisense or overlapping genes, which was
consistent with previous investigations characterizing
lncRNA expression across tissues8. While positively
correlated nearby genes could be indicative of an overall
chromatin state around these genes, these associations
could also reflect, in part, enhancer-like functions of
lncRNAs. For example, there are the following reports in
which: (i) siRNA-mediated depletion of lncRNAs leads
to decreased expression of neighboring genes;48 (ii)
lncRNAs transcribed from enhancer regions promote
expression of nearby genes by acting as a decoy for the
negative elongation factor complex in neurons49, and (iii)
enhancer lncRNAs can mediate chromosomal looping,
thereby bridging enhancers to their target genes50.
Therefore, our results identify 3 lncRNAs as candidates
for future functional studies designed to characterize
their regulatory roles over nearby antisense and over-
lapping genes.
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Fig. 3 Differentially expressed potential lncRNA cis gene targets. a–e RT-qPCR validation of differentially expressed antisense and overlapping
genes
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Table 2 Differentially expressed lncRNA distal gene targets and associated GO terms in the Blue and Brown modules
LncRNA Gene target Weight Associated GO GO class GO Description
CTC-487M23.5 (Blue module) KANK1 0.228 GO:0007155 BP Cell adhesion
GO:0032956 BP Regulation of actin cytoskeleton organiz…
GO:0005886 CC Plasma membrane
DOCK1 0.212 GO:0043547 BP Positive regulation of GTPase activity
FNBP1 0.212 GO:0005886 CC Plasma membrane
CTD-2647L4.4 (Blue module) YWHAH 0.229 GO:0003779 MF Actin binding
GO:0005886 CC Plasma membrane
RP11-453F18_B.1 (Blue module) KANK1 0.204 GO:0007155 BP Cell adhesion
GO:0032956 BP Regulation of actin cytoskeleton organiz…
GO:0005886 CC Plasma membrane
TJP1 0.199 GO:0016324 CC Apical plasma membrane
GO:0005886 CC Plasma membrane
DOCK1 0.212 GO:0043547 BP Positive regulation of GTPase activity
FNBP1 0.211 GO:0005886 CC Plasma membrane
RP11-273G15.2 (Blue module) TCF12 0.165 GO:0071837 MF HMG box domain binding
GM2A 0.154 GO:0005887 CC Integral component of plasma membrane
GO:0005886 CC Plasma membrane
GO:0016021 CC Integral component of membrane
SNCB 0.155 GO:0005509 MF Calcium ion binding
YES1 0.156 GO:0007155 BP Cell adhesion
GO:0005886 CC Plasma membrane
GO:0015629 CC Actin cytoskeleton
VAMP3 0.152 GO:0007155 BP Cell adhesion
GO:0005886 CC Plasma membrane
GO:0016324 CC Apical plasma membrane
GO:0009986 CC Cell surface
GO:0016021 CC Integral component of membrane
RDX 0.154 GO:0003779 MF Actin binding
GO:0007155 BP Cell adhesion
GO:0032956 BP Regulation of actin cytoskeleton organiz…
GO:0030027 CC Lamellipodium
GO:0016324 CC Apical plasma membrane
GO:0005615 CC Extracellular space
GO:0015629 CC Actin cytoskeleton
RUSC1 0.165 GO:0003779 MF Actin binding
GO:0005886 CC Plasma membrane
RP11-326I11.3 (Blue module) TJP1 0.200 GO:0016324 CC Apical plasma membrane
GO:0005886 CC Plasma membrane
DOCK1 0.199 GO:0043547 BP Positive regulation of GTPase activity
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Most importantly, the 3 differentially expressed genes
(LY6E, IRF2, and HMBOX1) identified as antisense to and
overlapping with differentially expressed lncRNAs all have
functions related to interferon (IFN) signaling. Among
these, LY6E was recently reported to be upregulated in
leukocytes from depressed patients after anti-depressant
treatment51. The IFN signaling system has an important
role in innate immune signaling as well as in CNS
homeostasis and in psychiatric disorders, including major
depression52. Therefore, our findings support the growing
literature implicating the immune system in depression,
and highlight the potential role of lncRNAs as mediators
of IFN dysfunction in this disorder as well as in suicide.
LncRNA potential associations with distal target genes
LncRNA genes have been shown to produce isoforms
with distinct functions carried out through cis or trans
regulatory mechanisms53. As such, a single lncRNA gene
could regulate several target genes which may be distally
located. Using WGCNA, we found that the Blue and
Brown modules significantly associated with depression.
GO analysis revealed an enrichment of protein-coding
genes involved in cytoskeleton remodeling and in inter-
actions between the cytoskeleton and the cell membrane
(Table 2) within these modules. Importantly, several of
these protein-coding genes were also associated with
differentially expressed lncRNAs found within the Blue
and Brown modules and some of these same genes were
reported to have roles in the regulation of cell migration
or in neural differentiation as well. For example, in the
Blue module, RDX is a cytoskeletal protein linking the
cytoplasm to the cell membrane54 that is also involved in
regulating cell growth and migration55. Taken together,
lncRNAs may be involved in the regulation of protein-
Table 2 continued
LncRNA Gene target Weight Associated GO GO class GO Description
FNBP1 0.220 GO:0005886 CC Plasma membrane
YWHAH 0.193 GO:0003779 MF Actin binding
GO:0005886 CC Plasma membrane
RP1-269M15.3 (Blue module) SGPL1 0.191 GO:0016021 CC Integral component of membrane
KANK1 0.222 GO:0007155 BP Cell adhesion
GO:0032956 BP Regulation of actin cytoskeleton organiz…
GO:0005886 CC Plasma membrane
DOCK1 0.198 GO:0043547 BP Positive regulation of GTPase activity
PPFIA1 0.195 GO:0007155 BP Cell adhesion
GO:0032956 BP Regulation of actin cytoskeleton organiz…
WASF2 0.189 GO:0003779 MF Actin binding
GO:0032956 BP Regulation of actin cytoskeleton organiz…
GO:0030027 CC Lamellipodium
GO:0015629 CC Actin cytoskeleton
RP11-434C1.1 (Brown module) CELSR3 0.130 GO:0046872 MF Metal ion binding
ATG3 0.122 GO:0016567 BP Protein ubiquitination
SRRM4 0.128 GO:0005634 CC Nucleus
DEK 0.122 GO:0003677 MF DNA binding
GO:0006355 BP Regulation of transcription, DNA-templat…
GO:0005634 CC Nucleus
GRIN1 0.124 GO:0046872 MF Metal ion binding
GO:0006355 BP Regulation of transcription, DNA-templat…
GO:0050773 BP Regulation of dendrite development
GO:0048813 BP Dendrite morphogenesis
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coding genes related to cytoskeletal and membrane
functions that can also underlie dysregulated neural cell
motility and differentiation in depression and suicide.
Many lncRNAs in the Blue and Brown modules were
also associated with genes (such as PPFIA1, SNCB, and
GRIN1) involved in the development of neural circuitry
and dendritic/synaptic morphology. Of note, SNCB has
been previously implicated in anti-depressant response56
and GRIN1 in depression57. Neuronal remodeling has
been long known to be associated with depression58, and
our data suggest that these processes may be regulated in
part through lncRNAs.
Finally, several lncRNA-associated protein-coding genes
(such as TCF12 and FNBP1) are implicated in both neural
processes involving cytoskeletal or membrane regulation
as well as processing of immune signaling and function.
Along with our findings that lncRNAs are associated with
overlapping and antisense genes involved in IFN signaling,
lncRNA associations with distal protein-coding genes also
involved in immune and neurological processes implicate
lncRNAs in regulating immune signals that may be sig-
nificant players underlying depression and suicide.
We would like to acknowledge that a higher threshold
value for module construction and detection was used
than the recommended default parameters suggested by
the developers of WGCNA (see Methods and Materials).
This was done to increase the power of detecting sig-
nificant modules after multiple testing corrections. While
this approach reduces the specificity of gene networks, it
would allow for the detection of broad significant net-
works of genes to provide an overall picture of the
molecular and biological processes contributing to
depression and suicide in the brain. Other studies taking a
network approach to analyzing suicide related genes have
treated suicide related genes as a “meta-system” of
interacting pathways and processes and have similarly
reported suicide related gene networks associated with
signal transduction pathways, actin-interacting proteins,
development/morphology phenotypes, and stress-
sensitive synaptic plasticity processes59. While our
results provide evidence in line with these previous find-
ings, interpretation of the association of specific genes,
including lncRNAs, need to be made with caution and
further experiments are required to provide the evidence
implicating their significance.
Limitations and future directions
The present study is not without limitations. As it is
often the case in studies of individuals who died by sui-
cide, comorbidity is more the rule than the exception60. It
is possible that some of the changes in the expression of
specific lncRNAs identified in our study might not gen-
eralize to all cases of depression and suicide, given that
factors such as history of early-life adversity or substance
use may explain part of the variance. Future experiments,
including animal models, should separate the relative
contribution of comorbid factors.
Additionally, we recognize that the associations
between lncRNAs and potential target genes need to be
validated with additional experiments. Manipulation of
lncRNA gene levels in vivo using animal models, or
in vitro using cell lines, would confirm their effects on
target genes, such as those identified from co-expression
networks. For example, Bagot et al.61 showed that the
overexpression of key network “hub genes” led to changes
in the expression of a significant number of genes which
were enriched with those belonging to the corresponding
co-expression network that was related to depression
susceptibility in mice. As lncRNA expression is tissue and
cell-type-specific, utilizing the appropriate systems in
which to probe lncRNA function becomes extremely
important, but also challenging. Furthermore, in silico
lncRNA target prediction tools can be used to supplement
disease association approaches, such as ours, to improve
target prediction62. Once promising lncRNA and target
candidates have been narrowed down, targeted validation
of RNA-RNA interactions, such as through RNA-
interactome analysis (RIA-seq), can be used to identify
direct binding partners of significant lncRNAs. The
results can also help determine the accuracy of lncRNA
target prediction approaches.
To conclude, to our knowledge, our study is the first to
report a detailed and comprehensive list of lncRNAs
expression in the brains of depressed individuals who died
by suicide. We identified several lncRNAs that are dif-
ferentially expressed in the rACC and found overlapping,
antisense, and more distally located protein-coding genes
significantly associated with these lncRNAs. Importantly,
many of the lncRNA associated genes were implicated
with immune processes, especially in IFN signaling, that
may be significant signals driving biological and molecular
changes in the brain. Altogether, our results uncover
dysregulated lncRNAs in depression and suicide, and
provide new molecular targets for follow-up post-mortem
and in vitro functional studies.
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